Last updated: March 29, 2024
Sponsor: Ataturk University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pain
Treatment
Group II: 60 Min Interval Time
Group I: 30 Min Interval Time
Clinical Study ID
NCT06329713
2024-03/11
Ages 25-45 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Healthy nulliparous women
- American Society of Anaesthesiology Score of II
- During active labor
- At weeks 37-42.
- Singlet vertex presentation
- Cervical dilation <5 cm at the request of labor analgesia
- VAS score >40
Exclusion
Exclusion Criteria:
- Age <20 or >45,
- Morbid obesity
- Presence of pregnancy-related comorbidities (e.g: gestational diebetes, gestationalhypertension and preeclampsia)
- History of drug abuse
- Contrindication for neuraxial blocks
- Conditions that increase the risk of need for cesarean section (e.g. placenta previa,uterus abnormalities or surgeries)
- Diagnosed fetal abnormalities
- Cases where dura gets punctured unintendedly with the epiduralneedle
- Cases where flow of cerebrospinal fluid (CSF) is not observed after dural puncture
- Cases where a cesarean section is performed at any stage of labor
- Cases where labor is completed in 1 hour from the start of analgesia procedure. Exclusion Criteria:
Study Design
Total Participants: 54
Treatment Group(s): 2
Primary Treatment: Group II: 60 Min Interval Time
Phase:
Study Start date:
March 15, 2024
Estimated Completion Date:
August 01, 2025
Study Description
Connect with a study center
Atatürk University
Erzurum,
TurkeyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.